Search

Your search keyword '"Reich, Adam"' showing total 1,393 results

Search Constraints

Start Over You searched for: Author "Reich, Adam" Remove constraint Author: "Reich, Adam" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
1,393 results on '"Reich, Adam"'

Search Results

1. Index

4. Notes

14. Preface

15. Contents

18. Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study

20. Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials

21. Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials

25. Pruritus

27. Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials

29. Contributors

31. The 'Connective Tissue Diseases'

34. Applying the Atomic Force Microscopy Technique in Medical Sciences—A Narrative Review.

35. Evaluation of hair surface structure and morphology of patients with lichen planopilaris (LPP) by atomic force microscopy (AFM).

36. Pruritus in Lichen Planopilaris and Frontal Fibrosing Alopecia—Clinical Characteristics and Dermoscopic Correlations.

37. Effectiveness and Safety of Etanercept in Paediatric Patients with Plaque-Type Psoriasis: Real-World Evidence.

38. Scleroderma and scleroderma-like syndromes.

39. Assessing health‐related quality of life using the Wound‐QoL‐17 and the Wound‐QoL‐14—Results of the cross‐sectional European HAQOL study using item response theory.

44. 523 - Efficacy and safety of amlitelimab (an anti-OX40 ligand antibody) in patients with moderate-to-severe atopic dermatitis: 24-week results from a phase 2b trial (STREAM-AD)

47. Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials

49. With God on Our Side

50. The “Connective Tissue Diseases”

Catalog

Books, media, physical & digital resources